Table 2.

Hospital admissions with infection (all admissions and common specific infections)

Practices grouped in quartiles of change in antibiotic prescribing 2012–18Admissions per 100 000 patients in Q1 2012Admissions per 100 000 patients in Q1 2018Change (95% CI) in rate per quarter 2012–18Change in rate per quarter (95% CI) compared with quartile one
All hospitalizationsa
 quartile 1 (no change)337.8410.13.68 (2.64 to 4.73)REF
 quartile 2312.3360.02.38 (1.46 to 3.31)−1.30 (−2.70 to 0.11)
 quartile 3320.1394.12.34 (1.18 to 3.49)−1.35 (−2.75 to 0.06)
 quartile 4 (largest fall)342.7401.52.18 (1.18 to 3.19)−1.50 (−2.91 to −0.10)
Bacterial pneumonia
 quartile 1 (no change)88.588.51.16 (0.39 to 1.94)REF
 quartile 286.286.20.95 (0.33 to 1.57)−0.21 (−1.20 to 0.78)
 quartile 389.489.40.98 (0.22 to 1.74)−0.18 (−1.17 to 0.81)
 quartile 4 (largest fall)98.898.80.67 (-0.09 to 1.42)−0.50 (−1.49 to 0.49)
Cellulitis
 quartile 1 (no change)45.346.00.30 (0.03 to 0.64)REF
 quartile 244.745.50.30 (0.04 to 0.57)−0.003 (−0.41 to 0.40)
 quartile 341.446.10.32 (0.05 to 0.59)0.01 (−0.40 to 0.42)
 quartile 4 (largest fall)38.946.70.45 (0.13 to 0.77)0.15 (−0.26 to 0.56)
COPD
 quartile 1 (no change)99.6106.40.51 (−0.08 to 1.10)REF
 quartile 286.386.20.24 (−0.27 to 0.76)−0.27 (−1.04 to 0.51)
 quartile 387.891.70.05 (−0.51 to 0.61)−0.46 (−1.23 to 0.32)
 quartile 4 (largest fall)97.5105.00.23 (−0.38 to 0.84)−0.28 (−1.06 to 0.49)
Practices grouped in quartiles of change in antibiotic prescribing 2012–18Admissions per 100 000 patients in Q1 2012Admissions per 100 000 patients in Q1 2018Change (95% CI) in rate per quarter 2012–18Change in rate per quarter (95% CI) compared with quartile one
All hospitalizationsa
 quartile 1 (no change)337.8410.13.68 (2.64 to 4.73)REF
 quartile 2312.3360.02.38 (1.46 to 3.31)−1.30 (−2.70 to 0.11)
 quartile 3320.1394.12.34 (1.18 to 3.49)−1.35 (−2.75 to 0.06)
 quartile 4 (largest fall)342.7401.52.18 (1.18 to 3.19)−1.50 (−2.91 to −0.10)
Bacterial pneumonia
 quartile 1 (no change)88.588.51.16 (0.39 to 1.94)REF
 quartile 286.286.20.95 (0.33 to 1.57)−0.21 (−1.20 to 0.78)
 quartile 389.489.40.98 (0.22 to 1.74)−0.18 (−1.17 to 0.81)
 quartile 4 (largest fall)98.898.80.67 (-0.09 to 1.42)−0.50 (−1.49 to 0.49)
Cellulitis
 quartile 1 (no change)45.346.00.30 (0.03 to 0.64)REF
 quartile 244.745.50.30 (0.04 to 0.57)−0.003 (−0.41 to 0.40)
 quartile 341.446.10.32 (0.05 to 0.59)0.01 (−0.40 to 0.42)
 quartile 4 (largest fall)38.946.70.45 (0.13 to 0.77)0.15 (−0.26 to 0.56)
COPD
 quartile 1 (no change)99.6106.40.51 (−0.08 to 1.10)REF
 quartile 286.386.20.24 (−0.27 to 0.76)−0.27 (−1.04 to 0.51)
 quartile 387.891.70.05 (−0.51 to 0.61)−0.46 (−1.23 to 0.32)
 quartile 4 (largest fall)97.5105.00.23 (−0.38 to 0.84)−0.28 (−1.06 to 0.49)
a

All hospitalizations includes: (i) bacterial pneumonia, cellulitis and COPD – these have also been analysed individually; (ii) sepsis and urinary infections – these have not been analysed individually due to non-linearity; and (iii) mastoiditis and peri-tonsillar infections – these have not been analysed individually as numbers are very small (Figure S1 and Table S2).

Table 2.

Hospital admissions with infection (all admissions and common specific infections)

Practices grouped in quartiles of change in antibiotic prescribing 2012–18Admissions per 100 000 patients in Q1 2012Admissions per 100 000 patients in Q1 2018Change (95% CI) in rate per quarter 2012–18Change in rate per quarter (95% CI) compared with quartile one
All hospitalizationsa
 quartile 1 (no change)337.8410.13.68 (2.64 to 4.73)REF
 quartile 2312.3360.02.38 (1.46 to 3.31)−1.30 (−2.70 to 0.11)
 quartile 3320.1394.12.34 (1.18 to 3.49)−1.35 (−2.75 to 0.06)
 quartile 4 (largest fall)342.7401.52.18 (1.18 to 3.19)−1.50 (−2.91 to −0.10)
Bacterial pneumonia
 quartile 1 (no change)88.588.51.16 (0.39 to 1.94)REF
 quartile 286.286.20.95 (0.33 to 1.57)−0.21 (−1.20 to 0.78)
 quartile 389.489.40.98 (0.22 to 1.74)−0.18 (−1.17 to 0.81)
 quartile 4 (largest fall)98.898.80.67 (-0.09 to 1.42)−0.50 (−1.49 to 0.49)
Cellulitis
 quartile 1 (no change)45.346.00.30 (0.03 to 0.64)REF
 quartile 244.745.50.30 (0.04 to 0.57)−0.003 (−0.41 to 0.40)
 quartile 341.446.10.32 (0.05 to 0.59)0.01 (−0.40 to 0.42)
 quartile 4 (largest fall)38.946.70.45 (0.13 to 0.77)0.15 (−0.26 to 0.56)
COPD
 quartile 1 (no change)99.6106.40.51 (−0.08 to 1.10)REF
 quartile 286.386.20.24 (−0.27 to 0.76)−0.27 (−1.04 to 0.51)
 quartile 387.891.70.05 (−0.51 to 0.61)−0.46 (−1.23 to 0.32)
 quartile 4 (largest fall)97.5105.00.23 (−0.38 to 0.84)−0.28 (−1.06 to 0.49)
Practices grouped in quartiles of change in antibiotic prescribing 2012–18Admissions per 100 000 patients in Q1 2012Admissions per 100 000 patients in Q1 2018Change (95% CI) in rate per quarter 2012–18Change in rate per quarter (95% CI) compared with quartile one
All hospitalizationsa
 quartile 1 (no change)337.8410.13.68 (2.64 to 4.73)REF
 quartile 2312.3360.02.38 (1.46 to 3.31)−1.30 (−2.70 to 0.11)
 quartile 3320.1394.12.34 (1.18 to 3.49)−1.35 (−2.75 to 0.06)
 quartile 4 (largest fall)342.7401.52.18 (1.18 to 3.19)−1.50 (−2.91 to −0.10)
Bacterial pneumonia
 quartile 1 (no change)88.588.51.16 (0.39 to 1.94)REF
 quartile 286.286.20.95 (0.33 to 1.57)−0.21 (−1.20 to 0.78)
 quartile 389.489.40.98 (0.22 to 1.74)−0.18 (−1.17 to 0.81)
 quartile 4 (largest fall)98.898.80.67 (-0.09 to 1.42)−0.50 (−1.49 to 0.49)
Cellulitis
 quartile 1 (no change)45.346.00.30 (0.03 to 0.64)REF
 quartile 244.745.50.30 (0.04 to 0.57)−0.003 (−0.41 to 0.40)
 quartile 341.446.10.32 (0.05 to 0.59)0.01 (−0.40 to 0.42)
 quartile 4 (largest fall)38.946.70.45 (0.13 to 0.77)0.15 (−0.26 to 0.56)
COPD
 quartile 1 (no change)99.6106.40.51 (−0.08 to 1.10)REF
 quartile 286.386.20.24 (−0.27 to 0.76)−0.27 (−1.04 to 0.51)
 quartile 387.891.70.05 (−0.51 to 0.61)−0.46 (−1.23 to 0.32)
 quartile 4 (largest fall)97.5105.00.23 (−0.38 to 0.84)−0.28 (−1.06 to 0.49)
a

All hospitalizations includes: (i) bacterial pneumonia, cellulitis and COPD – these have also been analysed individually; (ii) sepsis and urinary infections – these have not been analysed individually due to non-linearity; and (iii) mastoiditis and peri-tonsillar infections – these have not been analysed individually as numbers are very small (Figure S1 and Table S2).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close